Eva Maiken Holck

Eva Maiken Holck is a highly experienced regulatory affairs professional with a focus on CMC, currently serving as a RA CMC senior specialist at Nykode Therapeutics since October 2021. Previous roles include regulatory affairs CMC specialist at Novo Nordisk and EU, Canada, Australia, and New Zealand regulatory affairs business partner at LEO Pharma. Additionally, Eva held various positions at Novartis Consumer Health, including global regulatory affairs CMC manager II and I, as well as regulatory affairs manager. Early career experience includes serving as a regulatory affairs professional at LEO Pharma A/S. Eva holds a Master of Pharmaceutical Regulatory Affairs from Copenhagen University and a diploma in Pharmaceutical Regulatory Affairs from Medicademy, complemented by an MSc in Pharmaceutical Science from Danmarks Farmaceutiske Universitet.